![Weekly Enforcement Report: Drug Testing Fraud Dominates](https://www.g2intelligence.com/wp-content/uploads/2023/05/May17-2023.News_.WeeklyEnforcementReport.DrugTesting-iStock-1100-x-800-1080x675.jpg)
Weekly Enforcement Report: Drug Testing Fraud Dominates
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.
This model can help you create a whistleblower protection policy for your lab to encourage employees to voice their compliance concerns.
A False Claims Act whistleblower lawsuit can do significant damage to your lab and its reputation, even if the case lacks truth and merit.
The DOJ’s 2022 Fraud Statistics Overview shows it raked in less than 50 percent of what it recovered in FY 2021.